1. Home
  2. SINT vs DRMA Comparison

SINT vs DRMA Comparison

Compare SINT & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SINT
  • DRMA
  • Stock Information
  • Founded
  • SINT 1996
  • DRMA 2014
  • Country
  • SINT United States
  • DRMA United States
  • Employees
  • SINT N/A
  • DRMA N/A
  • Industry
  • SINT Medical/Dental Instruments
  • DRMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SINT Health Care
  • DRMA Health Care
  • Exchange
  • SINT Nasdaq
  • DRMA Nasdaq
  • Market Cap
  • SINT 4.8M
  • DRMA 4.5M
  • IPO Year
  • SINT 2014
  • DRMA 2021
  • Fundamental
  • Price
  • SINT $2.59
  • DRMA $0.73
  • Analyst Decision
  • SINT Strong Buy
  • DRMA Strong Buy
  • Analyst Count
  • SINT 1
  • DRMA 1
  • Target Price
  • SINT $30.00
  • DRMA $6.00
  • AVG Volume (30 Days)
  • SINT 85.7K
  • DRMA 4.2M
  • Earning Date
  • SINT 05-12-2025
  • DRMA 05-14-2025
  • Dividend Yield
  • SINT N/A
  • DRMA N/A
  • EPS Growth
  • SINT N/A
  • DRMA N/A
  • EPS
  • SINT N/A
  • DRMA N/A
  • Revenue
  • SINT $2,887,000.00
  • DRMA N/A
  • Revenue This Year
  • SINT N/A
  • DRMA N/A
  • Revenue Next Year
  • SINT N/A
  • DRMA N/A
  • P/E Ratio
  • SINT N/A
  • DRMA N/A
  • Revenue Growth
  • SINT 9.90
  • DRMA N/A
  • 52 Week Low
  • SINT $1.71
  • DRMA $0.69
  • 52 Week High
  • SINT $45.60
  • DRMA $6.17
  • Technical
  • Relative Strength Index (RSI)
  • SINT 52.90
  • DRMA 35.98
  • Support Level
  • SINT $1.72
  • DRMA $0.69
  • Resistance Level
  • SINT $2.78
  • DRMA $0.85
  • Average True Range (ATR)
  • SINT 0.22
  • DRMA 0.08
  • MACD
  • SINT 0.11
  • DRMA 0.00
  • Stochastic Oscillator
  • SINT 73.83
  • DRMA 25.00

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Share on Social Networks: